Winblad, S <br/><br/>
Cerebrospinal fluid tau and amyloid beta42 protein in patients with myotonic dystrophy type 1.  [electronic resource] 

 -  European journal of neurology  Sep 2008 
 - 947-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-1331 
<br/><br/><label>Standard No.: </label>10.1111/j.1468-1331.2008.02217.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Amyloid beta-Peptides--cerebrospinal fluid<br/>Biomarkers--cerebrospinal fluid<br/>Brain--pathology<br/>Cerebral Ventricles--pathology<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Myotonic Dystrophy--cerebrospinal fluid<br/>Neuropsychological Tests<br/>Peptide Fragments--cerebrospinal fluid<br/>Phosphorylation<br/>Protein Processing, Post-Translational<br/>tau Proteins--cerebrospinal fluid